AC Immune SA ACIU
Set alert
2.13 USD +0.07 +3.40%
As of Nov 3, 12:27 PM ET
2.06 Day range 2.16
2.02 52-week range 3.90
- YTD
- -32.17%
- 1 year
- -33.02%
- Open
- 2.06
- Prev close
- 2.06
- Mkt cap
- 212.28M
- Vol
- 54.67K
- Avg vol
- 204.51K
- EPS
- -0.54
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.06
- High
- 2.16
- Forward P/E
- -10.72
- Beta
- 1.28
- Short ratio
- 8.14
- Inst. own
- 28.82%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.11
- 200-d avg
- 3.32
- 1y target
- 10.01
6M chart
Signals (22)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| RSI: Oversold | Jun 5, 2026 | 5 months ago |
| RSI: Oversold | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
Newest 20 of 22.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.01 +369.8% upside
Now 2.13
- Target (low)
- 7.54
- Target (mean)
- 10.01
- Target (high)
- 15.77
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.187 | -0.201 – -0.17 | -0.05 | -274.0% | 556.43K | -96.2% | 3 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.18 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.536 | -0.552 – -0.52 | -0.64 | +16.3% | 26.79M | +81.0% | 2 |
| Next year | -0.03033 | -0.75 – 0.359 | -0.536 | +94.3% | 61.61M | +130.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 31, 2024 | BTIG | Initiated | — | Buy |
| Mar 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 19, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jul 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Dec 20, 2021 | SVB Leerink | Maintained | — | Outperform |
| Mar 24, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 10, 2019 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 1, 2019 | UBS | Downgrade | Buy | Neutral |
| Nov 13, 2018 | Leerink Swann | Initiated | — | Outperform |
| Apr 5, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 18, 2016 | Leerink Swann | Initiated | — | Outperform |